{"nct_id":"NCT02742090","title":"Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy","status":"TERMINATED","status_verified_date":"2024-06","start_date":"2016-04-21","start_date_type":"ACTUAL","primary_completion_date":"2021-06-10","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TGTX"]}